GE introduces Voluson Expert 22 ultrasound scanner

AuntMinnie.com staff writers
Jul 20, 2022
2021 11 30 16 39 4000 Ge Rsna 2021 400

GE Healthcare has unveiled Voluson Expert 22, a new ultrapremium ultrasound scanner that's optimized for applications in women's health.

The new system uses graphic-based beamformer technology, customizable user options, and clinical tools powered by artificial intelligence (AI). GE said the scanner also features the company's Lyric architecture, with advances in penetration, resolution, and frame rates that deliver improved 2D, 3D, and 4D ultrasound images.

The AI-powered tools meanwhile include SonoLyst for identifying fetal anatomy, SonoPelvicFloor, and SonoCNS. Customizable touch panels, color, and lighting options are also included. The scanner also sports a 23.8-inch high-definition display with three image sizes.

Latest in Ultrasound
Thyroid Cancer
Thermal ablation effective long term in patients with thyroid cancer
November 7, 2024
Baby Bottle
Could cranial ultrasound sub for brain MRI in imaging infants?
November 6, 2024
Images depict a 43-year-old woman with a malignant non-mass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic non-mass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected non-mass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
Ultrasound nonmass breast lesion features may signal malignancy
November 5, 2024
Chat Gpt 400
ChatGPT demonstrates mixed results in assigning BI-RADS categories
November 1, 2024
Related Stories
2021 11 30 16 39 4000 Ge Rsna 2021 400
MRI
GE's MRI recon software nabs new FDA clearance
2021 11 30 16 39 4000 Ge Rsna 2021 400
Artificial Intelligence
GE, Nex Cubed tap six AI startups for accelerator
2021 11 30 16 39 4000 Ge Rsna 2021 400
Digital X-Ray
GE releases new Definium 656 HD flagship fixed x-ray system
2021 11 30 16 39 4000 Ge Rsna 2021 400
Industry News
GE Healthcare Q2 sales edge up as profit dips
More in Ultrasound
Thermal ablation effective long term in patients with thyroid cancer
By Will Morton
Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.
November 7, 2024
Thyroid Cancer
Could cranial ultrasound sub for brain MRI in imaging infants?
By Amerigo Allegretto
Cranial ultrasound could have utility for imaging infants with hypoxic-ischemic encephalopathy.
November 6, 2024
Baby Bottle
Ultrasound nonmass breast lesion features may signal malignancy
By Amerigo Allegretto
Some nonmass breast lesion characteristics on ultrasound exams can be considered suspicious for malignancy at screening ultrasound.
November 5, 2024
Images depict a 43-year-old woman with a malignant non-mass lesion that was diagnosed as microinvasive ductal carcinoma. (A) Transverse and (B) longitudinal ultrasound images show a hypoechoic non-mass lesion (solid arrows) with segmental distribution in the left breast. The lesion has associated calcifications (dashed arrows in A). (C) Longitudinal color Doppler ultrasound image shows high vascularity. (D) Magnified image in the mediolateral oblique view from screening mammography shows grouped calcifications (arrows), which are considered a mammographic correlate of the ultrasound-detected non-mass lesion (A radiopaque marker attached to the skin is visible in the image because the mammographic exam was performed after screening breast ultrasound). Ultrasound-guided core needle biopsy and pathologic examination revealed ductal carcinoma in situ, but the lesion was upgraded to microinvasive ductal carcinoma at subsequent surgery (2.5-cm ductal carcinoma in situ, histologic grade II, estrogen receptor-positive, progesterone receptor-positive, human epidermal growth factor receptor type 2-negative).
ChatGPT demonstrates mixed results in assigning BI-RADS categories
By Amerigo Allegretto
ChatGPT achieves modest accuracy when assigning BI-RADS scores for mammograms and breast ultrasound exams.
November 1, 2024
Chat Gpt 400
ABUS screening improves breast cancer screening in low-resource areas
By Amerigo Allegretto
Automated breast ultrasound (ABUS) with remote reading may improve access to breast cancer screening and early detection in low-resource settings.
October 29, 2024
Ultrasound Breast 400
Ukraine's top pediatric hospital rebuilds after bomb attack
By Philip Ward
Radiology staff at the Ohmatdyt Children's Hospital in Kyiv are making steady progress with their plan to restore normal service after a devastating missile attack.
October 25, 2024
Thanks to the support of the global imaging community, radiology staff at the Ohmatdyt can now look forward to restoring normal service.
CNN models using ultrasound images detect pancreatic neoplasms
By Amerigo Allegretto
A deep-learning method using endoscopic ultrasound images could detect pancreatic neuroendocrine neoplasms.
October 18, 2024
Ultrasound Scanner Computerized 400
Ultrasound method detects cellular rejection in liver transplant cases
By Amerigo Allegretto
An ultrasound measurement technique could detect and stage acute cellular rejection in liver transplant patients.
October 16, 2024
Ultrasound Diagnostic Control Panel
Could elastography replace conventional ultrasound-guided FNAC?
By Amerigo Allegretto
Strain elastography does not have additional benefits over conventional elastography-guided FNAC for diagnosing malignancy in thyroid nodules.
October 15, 2024
Images depict a 43-year-old woman with a solitary left-sided thyroid nodule classified at gray-scale ultrasound as category U3, upgraded to category U4 at strain elastography, and classified as category Thy4 at cytopathologic examination. Subsequent surgical histopathologic examination confirmed papillary cell carcinoma. (A) Longitudinal view of the left thyroid lobe demonstrates the low reflective nodule (between arrows) measuring 13 × 12 × 11 mm (not shown) and with a halo. (B) A longitudinal image with side-by-side visualization of the nodule (arrow) at gray scale (left) and strain elastography (right). The nodule is predominantly blue, indicating increased stiffness. (C) A longitudinal view shows the needle (arrows) within the stiffer aspect of the nodule for cytology sampling. U and Thy categories are according to British Thyroid Association system. Image courtesy of the RSNA.
Ultrasound test detects 96% of ovarian cancers
By Kate Madden Yee
An ultrasound test can identify 96% of ovarian cancers in postmenopausal women, researchers have reported.
October 1, 2024
Ovarian Cancer
Publicly insured pregnant women less likely to get 20-week ultrasounds
By Amerigo Allegretto
Twenty-week ultrasound exams for pregnant women drives disparities in prenatal diagnosis of congenital heart defects.
September 23, 2024
Fetal Ultrasound
Lung ultrasound underdiagnoses pneumothorax in trauma patients
By Amerigo Allegretto
Lung ultrasound underdiagnoses clinically significant pneumothorax on initial trauma evaluation.
September 20, 2024
Ultrasound Probe Vascular
Page 1 of 512
Next Page